Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
H2A.Z histone pseudogene 7 (H2AZP7) is a processed pseudogene related to the histone variant H2A.Z. Unlike functional histone genes, H2AZP7 does not produce a protein product and is therefore not implicated in chromatin structure or gene regulation. It should not be confused with H2A.Z (proper), which is a crucial histone variant involved in nucleosome dynamics, transcription regulation, chromatin compaction, and DNA damage responses[1][2][6]. No evidence supports a role for H2AZP7 as a therapeutic target, biomarker, or disease-related gene. If you are seeking functional and therapeutic information, you should refer to **histone H2A.Z (H2AFZ)** rather than H2AZP7, as the latter is a nonfunctional pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on H2A.Z histone pseudogene 7 (H2AZP7).